• Saudi Arabia
register now

schedule details Agenda

schedule

Session I: Eosophageal cancer

Adenocarcinoma of the esophagus: What we know and what we do not know?

08:30 - 09:00

Satellite Symposium (Merck)

09:00 - 09:40

CROSS and adjuvant nivolumab vs FLOT
When to use CROSS approach
TNT in esophageal cancer
Adjuvant nivolumab after definitive chemoRT

Panel: Dr. Teresa Macarulla, Dr. Hani Eltaani, Dr. Fahad Ibnshamsah, Dr. Marwan AlHajeili, Dr. Ruaa Shafi, Dr. Kanan Alshammari, Dr. Maha Alidrisi, Dr. Faiz AlShafa, Dr. Nasser Saleh

Moderator: Dr. Mervat Mahrous

Session II: Perioperative therapy in Gastric Cancer

09:40-10:20

- Adjuvant therapy in case of no/limited response after preoperative FLOT -Perioperative therapy in MSI-H gastric cancer - Perioperative immunotherapy in gastric cancer Perioperative therapy in HER2+ gastric cancer

Panel: Dr. Turki Alfayea, Dr. Ali Alqahtani, Dr. Mohammed Bayamin, Dr. Fahad Ibnshamsah, Dr. Waleed AlSelwi, Dr. Ali Alfakeeh, Dr. Mohammad Algarni, Dr. Fahad Almugbel, Dr. Kamel Farag

Moderator: Dr. Ali Aljubran

SESSION III: Hepatobiliary cancers

Combining local and systemic therapy in HCC

09:50-10:30

Panel: Prof. Gamal Esmat, Dr. Adnan Alzanbagi, Dr. Waleed AlSelwi, Dr. Mervat Mahrous, Dr. Turki Alfayea, Dr. Kanan Alshammari, Dr. Ruaa Shafi, Dr. Mohammad Algarni

Moderator: Dr. Shereef Elsamany

10:30-11:00

Satellite Symposium (GSK)

SESSION IV: Gyne-Oncology

HIPEC in ovarian cancer

11:30 - 12:10

Panel: Dr. Abdulaziz Alzahrani, Dr. Ahmed Refae, Dr. Ehab Elnakoury, Dr. Basel Refky, Dr. Omima Elemam, Prof. Ahmed Badheeb, Dr. Saleh Alzahrani

Moderator: Dr. Waleed Bahaj

Neoadjuvant therapy in MSI-H colon cancer: Yes/No

12:10 - 12:30

Neoadjuvant therapy in colon cancer: Yes/No

12:30 - 12:45

Discussion

Panel: Dr. Kamel Farag, Dr. Sakher Abdullah, Dr. Saleh Alzahrani, Dr. Ehab El Hosseny, Prof. Maha Elzaafarany

Moderator: Dr. Ahmed Refae

12:45 - 13:30

Case-based presentation CRC with peritoneal metastasis: HIPEC/No HIPEC

Panel: Dr. Teresa Macarulla, Dr. Ali Alfakeeh, Dr. Marwan AlHajeili, Dr. Ali Aljubran, Dr. Fahad Almugbel, Dr. Abdulaziz Alzahrani, Dr. Ehab El Hosseny, Dr. Saleh Alzahrani

Moderator: Dr. Ali Alqahtani

13:30 - 13:35

CONCLUSION

SESSION I: GU cancers

8:30 - 9:00

Sequencing of Systemic Therapy in Advanced Prostate Cancer

Panel: Dr. Hussien Khalid, Dr. Hani Elkhatib, Dr. Mubarak Almansour, Dr. Abdullah Alsharm, Dr. Faisal Albadainah, Dr. Jawaher Ansari, Dr. Rula Almufti, Dr. Amin Eltigani

Moderator: Dr. Emad Tashkandi

09:00 - 9:30

Advanced Bladder Cancer: Optimal Therapeutic Strategy

Panel: Dr. Hussien Khalid, Dr. Hani Elkhatib, Dr. Abdullah Alsharm, Dr. Faisal Albadainah, Dr. Jawaher Ansari, Dr. Rula Almufti, Dr. Emad Tashkandi, Dr. Amin Eltigani

Moderator: Dr. Mubarak Almansour

SESSION II: Brain Germinoma

09:30 - 10:00

Therapeutic Challenges

Panel: Dr. Hussien Khalid, Dr. Hani Elkhatib, Dr. Mubarak Almansour, Dr. Faisal Albadainah, Dr. Rula Almufti, Dr. Emad Tashkandi, Dr. Ibrahim Madkhali, Dr. Nasser Al-Dhaibani

Moderator: Dr. Abdullah Alsharm

10:00 - 10:30

Satellite Symposium (Novartis)

10:30 - 10:40

Break

SESSION III: Breast Cancer

Breast Sarcoma: Challenges and Therapeutic Recommendations

10:40 - 11:20

Adjuvant therapy in low ER+/HER2 negative BC CDK4-6 inhibitors+hormonal therapy in metastatic low ER+/HER2-negative or ER-negative/PR+ve breast cancer Adjuvant CDK4-6 inhibitors in node-negative breast cancer

Panel: Dr. Esam Murshid, Dr. Abdulrahman Alshehri, Dr. Sherif kullab, Dr. Atlal Abusanad, Dr. Maha Alidrisi, Dr. Nasser Al-Dhaibani , Dr. Mariam Alsulami, Dr. Emad Alsharif

Moderator: Ahmed Zeeneldin

11:20 - 12:00

Opening Ceremony

12:00 - 13:45

Prayer& Lunch

13:45 - 14:15

Satellite Symposium (MSD)

Session IV: Breast Cancer

CDK4/6 inhibitors post progression- YES/NO

14:15 - 14:30

CDK4/6 inhibitors post progression- YES

14:30 - 14:45

CDK4-6 inhibitors post progression- NO

14:45 - 15:00

Panel discussion:

Panel discussion: Dr. Khalid Alsaleh, Dr. Mohamed Awad Ebrahim, Dr. Majid Aljahel, Dr. Bassam Basulaiman

Moderator: Dr. Sherif kullab

SESSION V: Breast Cancer

Hormonal-based therapy in HR+/HER2- BC

15:00 - 15:30

Adjuvant therapy in low ER+/HER2 negative BC CDK4-6 inhibitors+hormonal therapy in metastatic low ER+/HER2-negative or ER-negative/PR+ve breast cancer Adjuvant CDK4-6 inhibitors in node-negative breast cancer

Panel: Dr. Ahmed Alshehri, Dr. Khalid Alsaleh, Dr. Bassam Basulaiman, Dr. Mohamed Ali, Dr. Shereen Elshorbagy, Dr. Shereef Elsamany, Dr. Omima Elemam

Moderator: Dr. Adher Alsayed

15:30 - 15:40

Break

SESSION VI: Breast Cancer

HER2-low/ultra-low; Pathological and clinical perspectives?

15:40 - 16:10

Cutoff low vs. ultra-low?? Which staining platform??
Can we use TDX-D without HER2-testing?
How to choose between available ADCs?

Panel: Dr. Ahmed Alfaraj, Dr. Ahmed Zeeneldine, Dr. Ibtessam Saadeldin , Dr. Atlal Abusanad, Dr. Majid Aljahel, Dr. Mohamed Awad Ebrahim, Dr. Sherif kullab, Dr. Rasha Haggag

Moderators: Dr. Hatim Al Maghrabi Dr. Aboelkhair Algahami

SESSION VII: Breast Cancer

Adjuvant therapy in TNBC

16:10 - 16:40

Adjuvant immunotherapy after NAC without immunotherapy Adjuvant carboplatin after upfront surgery: Yes/No Adjuvant immunotherapy in case of pCR Adjuvant capecitabine: Basal vs. Non-basal TNBC

Panel: Dr. Esam Murshid, Dr. Bassam Basulaiman, Dr. Abdulrahman Alshehri, Dr. Ahmed Alfaraj, Dr. Aboelkhair Algahami, Dr. Atlal Abusanad, Dr. Adher Alsayed, Dr. Mohamed Ali

Moderators: Dr. Ahmed Alshehri

16:40 - 17:00

Break

Session IX: Breast Cancer

Consensus Panel of the management of early lobular BC

17:00 - 17:40

Panel

Dr. Esam Murshid, Dr. Ahmed Alshehri, Dr. Ahmed Alfaraj, Dr. Abdulrahman Alshehri, Dr. Ahmed Zeeneldine, Dr. Mohamed Awad Ebrahim, Dr. Khalid Alsaleh, Dr. Ibtessam Saadeldin, Dr. Adher Alsayed, Dr. Shereen Elshorbagy, Dr. Khaled Galal

Moderator: Dr. Shereef Elsamany

Day 2 Conclusion

Opening

SESSION I

Chairpersons : Dr. Sami Alshammary , Dr. Rami Faraj, Dr. Hasan M. Alkhudairi

6:00 – 6:15

Role of Antibiotic at EOL

6:15 – 6:30

Management of terminal Delirium

6:30 – 6:45

Refractory seizure in brain metastasis

6:45 – 7:00

Pons and cons of opioid withdrawing in patient with coma

7:00 – 7:15

Discussion

7:15 – 7:30

Break

SESSION II

Moderators: Prof. Hafez Ghanem, Dr. Gomaa Abdelfattah , Dr. Abdullah Alshehri

7:30 – 7:45

Debates about Palliative sedation

7:45 – 8:00

Role of VTE prophylaxis in palliative patients

8:00 – 8:15

Q&A in cancer patients with cachexia

8:15 – 8:30

Insomnia in terminally ill patients

8:30 – 8:45

Benefit and limitation of CNS stimulant in treating fatigue

8:45 – 9:00

Discussion

9:00 – 9:30

SATELLITE SYMPOSIUM (Janssen)

9:30 – 10:30

DINNER

© 2024 debats in oncology. All rights reserved

Developed By | Event Troop Logo

Contact Us
1